1.gif (1892 bytes)

Case Reports

Indian Pediatrics 2001; 38: 419-422  

Castlemans’s Disease : An Unusual Presentation in Cervical Region


Ranka Satish R.
Rajput Ashish
Kantharia Chetan V.

From the Department of Surgery, Seth G.S. Medical College and K.E.M. Hospital, Mumbai 400 012, MS, India.
Corresondence to: Dr. Ranka Satish R, 22, Avanti Apartment, S.B. Marg, Dadar West, Mumbai 400 028, MS, India.
E-mail:
[email protected]

Manuscript received: July 20, 2000;
Initial review completed: August 29, 2000;
Revision accepted: October 3, 2000.

Castleman’s disease is an unusual lymphoproliferative disorder of unknown cause. It is a clinicopathological diagnosis. We report the hyaline vascular variant of this entity occurring in the cervical region of a child. Reactive lymphoproliferative process in response to an unknown stimulus and defective immunoregulation may be involved in its pathogenesis(1).

 Case Report

A 12-year-old boy presented to the Surgical Out Patient Department with a lump in right cervical region since 3 months. On further inquiry he gave history of constitutional symptoms like low grade fever since 2 months and loss of appetite. General examination was unremarkable and local examination of the region revealed a 7 cm ´ 4 cm nontender lymphnode mass with irregular surface and a firm consistency. His hemoglobin was 11 g/dl, total leukocyte count was 7600/cu mm (P: 45, L: 40) and ESR was 37 mm at the end of one hour. X-ray chest was normal. Fine needle aspiration cytology was reported as reactive hyperplasia. In view of strong clinical suspicion of tuberculosis, lymph node biopsy was performed. Histopathological examination revealed concentrically layered (onion-skin like) follicular cells with squamatoid appear-ance and a pseudofollicle with a hyalinized vessel suggestive of a variant of Castleman’s disease (Fig. 1). In view of this report we excised the whole mass. Six months after surgery, the patient was asymptomatic and there was no local recurrence. The patient was advised to follow up periodically at an interval of 3 months.


Fig. 1. Centre of pseudofollicle showing a thickened vessel with concentric layers of proliferating endothelium surrounded by concentric packed lymphocytes. (HE
´ 40).

 Discussion

Castleman’s disease is a benign lympho-proliferative disorder characterized by enlarged hyperplastic lymph nodes which is rare in children(2). In 1956 Benjamin Castleman and his associates described this disease(3). Since then it is also recognized as angiofollicular lymphoid hyperplasia, giant lymph node hyperplasia, lymphoid hyperplasia, benign lymphoma, and follicular lympho-reticuloma(4). It can present as a localized mass or as a multicentric disorder. Its presentation as primary cervical lymph-adenopathy accounts for only 6% of cases reported in literature(5). Histologically, three variants are recognized, viz., hyaline vascular, plasma cell type, and intermediate type(6). Hyaline-vascular type is the most commonest presentation. This type is usually localized to mediastinum or pulmonary hilum(7). This is in contrast to our patient who presented with cervical lymphadenopathy. Parez et al. reviewed 76 cases of Castlemans disease reported in literature in pediatric age group and found that 54% of them had a localized hyaline vascular type of disease in mediastinum and rarely in cervical region as compared to the plasma cell type which occurred in 24% of the patients(8). It has been recently suggested that an abnormal production of a B cell growth factor, such as IL-6, causing lympho-proliferation and plasma cell differentiation may be the key factor in pathogenesis of Castleman’s disease(7). Localized disease usually has a benign course and can present as an asymptomatic mass or with compression effect in respective area and also as pyrexia of unknown origin, weight loss or anemia(9). Multicentric disease is a usually a systemic illness involving retroperitoneum, neck, parotids and muscles or it can present as a disseminated lymphadenopathy. It is aggressive and usually the fatal course is associated with infectious complications and risk for malignant tumors such as lymphoma or Kaposi sarcoma.

The classical histopathological picture consists of presence of thickened hyalinized capillaries within the follicle centres. Also there is perifollicular vascular proliferation with concentric layering of cells within germinal centres. There may be more than one germinal center within a single follicle.

Following the histological report, we excised the whole mass as surgery is curative for localized disease. Multicentric disease is usually associated with systemic manifestations and its prognosis is guarded. Its management includes a multimodality approach comprising of surgery, combination chemotherapy, steroids and radiation. lately anti-interleukin–6 receptor antibody therapy has been tried(10).

Contributors: RSR was responsible for reviewing the literature and drafting the paper; he will act as guarantor for the paper. RA and KCV helped in drafting the paper.

Funding: None.
Competing interests:
None stated.

Key Messages

  • Castleman’s disease may mimic a neoplasm and should be considered in presence of a solitary neck mass.

  • There is a 100% five year survival with a localized disease if completely excised.

 References
  1. Cioffi U, Simone M De, Nosotti M, Bellaviti N, Naimzada An, Ferrero S et al. Hyaline vas-cular Castleman’s disease of the mediastinum. Inter Surg 1999; 84: 114-117.

  2. Tuerlinckx D, Bodart E, Delos M, Ramacle M, Ninanc J. Unifocal cervical Castleman’s disease in two children; Eur J Pediatr 1997; 156: 701-703.

  3. Castleman B, Iverson L, Menendez VP. Localized lymphonode hyperplasia. Cancer 1956; 9: 822-830.

  4. Herrada J. Cabanillas F, Rice L, Mannins J, Pugh W. The clinical behavior of localized and multicenteric Castleman’s disease. Ann Intern Med 1998; 128: 657-662.

  5. Kumar BN, Jones TJ, Skinner DW. Castle-man’s Disease: An unusal cause of a neck mass. Oto-Rhino-Laryngol 1997; 59: 339-340.

  6. Halkic N. Cornu P, Mosimann F. Castleman’s disease: Two unusual cases. Swissede Med 1998; 128: 331-336.

  7. Palestro G, Turrini F, Pagano M, Chiusa L. Castleman’s disease. Adv Clin Pathol 1999; 3: 11-22.

  8. Parez N, Bader-Meunier B, Roy CC, Dommergues JP. Pediatric Castleman’s disease: Report of seven cases and review of the literature. Euro J Pediatr 1999; 158: 631-637.

  9. Wick MR. The Mediastinum. In: Diagnostic Surgical Pathology, Vol. 1,2nd edn. Eds. Sternberg SS. New York, Lippincott-Raven Publishers, 1994; pp 1125-1141.

  10. Nishimoto N, Sasai M, Shima Y, Nakaguwa M, Matsumoto T, Shirai T, et al. Improvement in Castleman’s disease by humanised anti- interkeukin-6 receptor antibody therapy. Blood 2000; 95: 56-61.

Home

Past Issue

About IP

About IAP

Feedback

Links

 Author Info.

  Subscription